' Stunning ' Twincretin Beats Semaglutide in Type 2 Diabetes ' Stunning ' Twincretin Beats Semaglutide in Type 2 Diabetes

Head-to-head pivotal trial results show weekly tirzepatide injections surpassed 1 mg semaglutide weekly for A1c reduction and weight loss as second-line therapy after metformin in type 2 diabetes.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news